Fund Holdings — DAFNA Capital Management LLC

Total Portfolio Value:
$423.31M
Total Bought:
$27.41M
Total Sold:
$34.46M
Net Transaction:
-$7.06M
Notable People:
Nathan Fischel, Fariba Fischel Ghodsian, Dafna Holdings, L.P.
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Spdr S&p Biotech EtfETF
ST STR SP BIOT
445,005401,505-43,500$41.26M$39.67M9.37%-$1.59M
Stereotaxis, Inc.(STXS)13,680,55413,680,5540$24.90M$27.91M6.59%+$3.01M
Revolution Medicines, Inc.(RVMD)511,894517,994+6,100$19.87M$23.49M5.55%+$3.62M
Cytokinetics, Incorporated(CYTK)398,100398,1000$21.57M$21.02M4.97%-$549.4K
Merus N V409,445412,573+3,128$24.23M$20.61M4.87%-$3.61M
AtriCure, Inc.(ATRC)639,173641,673+2,500$14.55M$17.99M4.25%+$3.44M
IDEAYA Biosciences, Inc.(IDYA)422,213471,410+49,197$14.82M$14.93M3.53%+$110.4K
Ishares Nasdaq Biotech IndxETF102,500102,5000$14.07M$14.92M3.53%+$854.9K
Ascendis Pharma A/SADR(ASND)80,97289,572+8,600$11.04M$13.37M3.16%+$2.33M
Axogen, Inc.(AXGN)935,894935,8940$6.78M$13.12M3.10%+$6.35M
Blueprint Medicines Corp104,763121,763+17,000$11.29M$11.26M2.66%-$28.3K
Xenon Pharmaceuticals Inc.(XENE)273,739273,7390$10.67M$10.78M2.55%+$104.0K
Day One Biopharmaceuticals I
COM
666,463750,363+83,900$9.18M$10.45M2.47%+$1.27M
Syndax Pharmaceuticals, Inc.(SNDX)657,074526,702-130,372$13.49M$10.14M2.40%-$3.35M
Biohaven Ltd.(BHVN)218,730187,130-31,600$7.59M$9.35M2.21%+$1.76M
Tandem Diabetes Care, Inc.(TNDM)204,208204,2080$8.23M$8.66M2.05%+$432.9K
Kalvista Pharmaceuticals Inc806,973723,678-83,295$9.51M$8.38M1.98%-$1.13M
Neurocrine Biosciences, Inc.(NBIX)71,61569,615-2,000$9.86M$8.02M1.89%-$1.84M
Kura Oncology, Inc.(KURA)423,500408,368-15,132$8.72M$7.98M1.89%-$740.4K
Viking Therapeutics, Inc.(VKTX)189,117125,616-63,501$10.03M$7.95M1.88%-$2.07M
Edgewise Therapeutics, Inc.(EWTX)290,197227,906-62,291$5.23M$6.08M1.44%+$856.4K
UroGen Pharma Ltd.(URGN)469,000458,915-10,085$7.87M$5.83M1.38%-$2.04M
BioCryst Pharmaceuticals, Inc.(BCRX)704,500667,000-37,500$4.35M$5.07M1.20%+$715.4K
Ascendis Pharma A/SNOTE 2 250 4 0(ASND)000$4.42M$4.68M1.11%+$260.0K
DexCom, Inc.(DXCM)65,55265,5520$7.43M$4.39M1.04%-$3.04M
Keros Therapeutics, Inc.(KROS)67,75473,754+6,000$3.10M$4.28M1.01%+$1.19M
Alector Inc912,928912,9280$4.14M$4.25M1.00%+$109.6K
Arcus Biosciences, Inc.(RCUS)253,217256,717+3,500$3.86M$3.93M0.93%+$68.7K
Lakefront Biotherapeutics NVADR(LKFT)130,175130,1750$3.23M$3.75M0.89%+$522.0K
Insulet Corporation(PODD)15,90015,9000$3.21M$3.70M0.87%+$492.1K
Alkermes plcSHS(ALKS)120,700120,7000$2.91M$3.38M0.80%+$469.5K
Larimar Therapeutics, Inc.(LRMR)639,974494,274-145,700$4.64M$3.24M0.76%-$1.40M
Perspective Therapeutics, Inc.(CATX)231,634230,322-1,312$2.31M$3.07M0.73%+$765.4K
2seventy Bio Inc1,050,709630,029-420,680$4.05M$2.97M0.70%-$1.07M
Acelyrin Inc693,609602,894-90,715$3.06M$2.97M0.70%-$86.5K
Allogene Therapeutics Inc605,1001,050,118+445,018$1.41M$2.94M0.69%+$1.53M
Aquestive Therapeutics Inc530,000589,561+59,561$1.38M$2.94M0.69%+$1.56M
Century Therapeutics, Inc.(IPSC)1,704,2321,704,2320$4.35M$2.91M0.69%-$1.43M
Astria Therapeutics Inc274,165254,165-20,000$2.49M$2.80M0.66%+$303.5K
Bicycle Therapeutics PlcADS122,200122,2000$2.47M$2.77M0.65%+$292.1K
Stoke Therapeutics, Inc.(STOK)207,427207,4270$2.80M$2.55M0.60%-$253.1K
BrainsWay Ltd.ADS(BWAY)297,655251,346-46,309$1.81M$2.32M0.55%+$515.7K
Lexeo Therapeutics, Inc.(LXEO)0250,583+250,583$0$2.27M0.54%+$2.27M
Accuray Inc1,222,3581,222,3580$2.22M$2.20M0.52%-$24.4K
ARS Pharmaceuticals, Inc.(SPRY)239,194148,294-90,900$2.04M$2.15M0.51%+$114.7K
Inogen, Inc.(INGN)208,790208,7900$1.70M$2.03M0.48%+$327.8K
Centessa Pharmaceuticals PlcADS122,882120,351-2,531$1.11M$1.92M0.45%+$814.8K
Mineralys Therapeutics, Inc.(MLYS)119,000146,500+27,500$1.39M$1.77M0.42%+$381.8K
Autolus Therapeutics plcADS(AUTL)346,667486,667+140,000$1.21M$1.77M0.42%+$560.2K
Immatics N.V.SHS(IMTX)145,000145,0000$1.68M$1.65M0.39%-$30.4K
Iteos Therapeutics Inc144,360161,584+17,224$2.14M$1.65M0.39%-$492.5K
Proqr Therapeutics N VSHS EURO
SHS EURO
905,582905,5820$1.50M$1.65M0.39%+$144.9K
COMPASS Pathways plcADS(CMPS)243,210243,2100$1.47M$1.53M0.36%+$63.2K
Structure Therapeutics IncADS5,00034,000+29,000$196.3K$1.49M0.35%+$1.30M
Immunovant, Inc.(IMVT)47,91651,996+4,080$1.26M$1.48M0.35%+$217.4K
Regulus Therapeutics Inc895,200895,2000$1.60M$1.41M0.33%-$192.5K
Gossamer Bio, Inc.(GOSS)1,409,2621,419,262+10,000$1.27M$1.40M0.33%+$130.4K
Lineage Cell Therapeutics, Inc.(LCTX)1,350,7081,350,7080$1.35M$1.22M0.29%-$124.3K
MediWound Ltd.SHS NEW(MDWD)124,47964,479-60,000$1.93M$1.16M0.28%-$767.4K
Sutro Biopharma, Inc.(STRO)329,579329,5790$965.7K$1.14M0.27%+$174.7K
PolyPid Ltd.(PYPD)184,846308,497+123,651$794.8K$1.06M0.25%+$266.4K
Nyxoah S ASHS
SHS
108,108108,1080$753.5K$1.03M0.24%+$278.9K
BioNTech SEADS(BNTX)08,500+8,500$0$1.01M0.24%+$1.01M
Adicet Bio Inc600,000600,0000$726.0K$864.0K0.20%+$138.0K
Compugen Ltd.(CGEN)462,202447,202-15,000$776.5K$809.4K0.19%+$32.9K
Acrivon Therapeutics Inc121,351112,414-8,937$703.8K$786.9K0.19%+$83.1K
Sage Therapeutics Inc116,200108,200-8,000$1.26M$781.2K0.18%-$480.7K
GRAIL, Inc.(GRAL)048,800+48,800$0$671.5K0.16%+$671.5K
ADC Therapeutics SASHS(ADCT)204,081204,0810$644.9K$642.9K0.15%-$2.0K
Black Diamond Therapeutics I0125,000+125,000$0$543.8K0.13%+$543.8K
Tourmaline Bio Inc75,98219,110-56,872$977.1K$491.3K0.12%-$485.8K
Tessera Defense and Homeland Security Inc.(HLSQ)0401,136+401,136$0$409.2K0.10%+$409.2K
Masimo Corp3,0003,0000$377.8K$400.0K0.09%+$22.2K
Verastem, Inc.(VSTM)0127,700+127,700$0$381.8K0.09%+$381.8K
Aprea Therapeutics, Inc.(APRE)137,174137,1740$558.3K$377.2K0.09%-$181.1K
Foghorn Therapeutics Inc.(FHTX)41,85037,664-4,186$240.6K$350.7K0.08%+$110.0K
Neurogene Inc.(NGNE)11,0007,775-3,225$400.3K$326.2K0.08%-$74.1K
Adaptimmune Therapeutics plcADR(ADAPY)341,064341,0640$332.5K$324.1K0.08%-$8.4K
Alto Neuroscience, Inc.(ANRO)120,00026,786-93,214$1.28M$306.4K0.07%-$976.4K
Neuronetics, Inc.(STIM)313,717313,7170$564.7K$238.4K0.06%-$326.3K
Compass Therapeutics, Inc.(CMPX)116,882116,8820$116.9K$215.1K0.05%+$98.2K
Nevro Corp28,00038,000+10,000$235.8K$212.4K0.05%-$23.3K
Spero Therapeutics, Inc.(SPRO)125,000125,0000$162.5K$167.5K0.04%+$5.0K
Karyopharm Therapeutics Inc.(KPTI)192,678192,6780$167.2K$159.9K0.04%-$7.2K
Morphic Holding Inc231,7480-231,748$7.90M$0—-$7.90M
ORIC Pharmaceuticals, Inc.(ORIC)36,0000-36,000$254.5K$0—-$254.5K
PROCEPT BioRobotics Corporation(PRCT)13,9940-13,994$854.9K$0—-$854.9K
Syros Pharmaceuticals Inc135,8500-135,850$701.0K$0—-$701.0K
Terns Pharmaceuticals Inc86,0000-86,000$585.7K$0—-$585.7K
Page 1 of 1
DAFNA Capital Management LLC — 13F Holdings — Q3 2024 | TickerTrail